Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Biomarker company forecasts second-quarter revenue drop
July 30th, 2004
Ciphergen Biosystems, Inc., (CIPH) announced its preliminary revenue forecast for the second quarter ending June 30, 2004 will be approximately $10.0-11.0 million, as compared to revenue of approximately $14.3 million in the second quarter of 2003. This preliminary revenue estimate is subject to final accounting and audit processes, and therefore could change. William E. Rich, president and CEO, commented: "After meeting our expectations in the first quarter, our ProteinChip System placements came in significantly short of our expectations and BioSepra sorbent revenue was down from the second quarter of last year. We believe that overall spending on...
Source: Genomics & Genetics Weekly (2004-07-30)
|
